Molecular Medicine Today logo Elsevier logo

Publisher: Elsevier

Volume 6, Number 11, 1 November 2000
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

How Escherichia coli kills
pp. 411-411(1)
Author: Greener M.

Immunomodulation in DNA damage and repair
pp. 411-412(2)
Author: Sansom C.

New diagnostic test for lupus
pp. 412-413(2)
Author: Dorrell S.

SLAM the door on measles
pp. 414-414(1)
Author: Brooksbank R.

An opportune moment to sequence an opportunistic pathogen
pp. 414-415(2)
Author: Mungall A.J.

New hope for spinal-cord repair from immune activation
pp. 415-415(1)
Author: Gurwitz D.

Angiogenic wisdom
pp. 416-416(1)
Author: Weitzman J.B.

Germ therapy with IL-10 to treat inflammatory bowel diseases
pp. 416-416(1)
Author: Michie C.

The ABCR of visual impairment
pp. 417-417(1)
Author: Aldred M.A.

Molecular aberrations in human systemic lupus erythematosus
pp. 418-424(7)
Authors: Tsokos G.C.; Kammer G.M.

Mitochondrial DNA mutations in the pathogenesis of human disease
pp. 425-432(8)
Authors: Chinnery P.F.; Turnbull D.M.

Adeno-associated virus vectors for gene therapy: more pros than cons?
pp. 433-440(8)
Authors: Monahan P.E.; Samulski R.J.

NF-kappaB as a therapeutic target in chronic inflammation: recent advances
pp. 441-448(8)
Author: Makarov S.S.

Murine, canine and non-human primate models of Krabbe disease
pp. 449-451(3)
Author: Wenger D.A.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A